Nondialysis-Dependent Chronic Kidney Disease
Iron deficiency linked to kidney outcomes in non-dialysis-dependent CKD without anemia
Iron deficiency may be linked to non-dialysis-dependent chronic kidney disease and mortality in patients without anemia, according to results of a nationwide cohort study.
Loss of lean soft tissue may correlate with BMD changes for some adults with CKD
Changes in body composition may correlate with bone mineral density fluctuations in non-dialysis-dependent chronic kidney disease, according to a cohort study.
VIDEO: Expert discusses impact of vadadustat data for non-dialysis CKD
Vadadustat did not meet the primary safety endpoint of the PRO2TECT program for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease, according to data presented at ASN Kidney Week.
VIDEO: Roxadustat maintains hemoglobin levels regardless of iron status
Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and co-chair of the Nephrology News & Issues Editorial Advisory Board, talked about a subanalysis presented at ASN Kidney Week on roxadustat.
VIDEO: Anemia treatment ‘inadequate’ in non-dialysis CKD
In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine, discussed the insufficiency of current anemia treatment for non-dialysis-dependent patients with chronic kidney disease.
Roxadustat effective in patients with CKD even with iron depletion
In clinical trials, patients with nondialysis-dependent chronic kidney disease using the hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat saw an increase in hemoglobin levels regardless of their iron status, according to an abstract presented at the virtual National Kidney Foundation Spring Clinical Meetings.